Overview
Biomakers, a precision medicine and oncology intelligence company based in San Francisco, has secured an additional $8 million in funding. This investment will help the company transition to an AI-native platform aimed at enhancing drug and diagnostic development, improving clinical trial execution, and broadening access to precision oncology worldwide. Key investors include Labcorp Venture Fund, Oncology Ventures, and others.
Products
Loading...
Recent Deals
Investors: Labcorp Venture Fund, Oncology Ventures
Biomakers, a precision medicine and oncology intelligence company based in San Francisco, has secured an additional $8 million in funding. This investment will help the company transition to an AI-native platform aimed at enhancing drug and diagnostic development, improving clinical trial execution, and broadening access to precision oncology worldwide. Key investors include Labcorp Venture Fund, Oncology Ventures, and others.